Suppr超能文献

患者是否在服用不安全的膳食补充剂?

Is My Patient Taking an Unsafe Dietary Supplement?

机构信息

Senior vice president of pharmacy practice and government affairs at the American Pharmacists Association in Washington, DC.

Former director of health policy at the American Pharmacists Association in Washington, DC.

出版信息

AMA J Ethics. 2022 May 1;24(5):E390-395. doi: 10.1001/amajethics.2022.390.

Abstract

Dietary supplements do not require premarket approval by the US Food and Drug Administration (FDA), yet they can have side effects; interact with medications, food, or other supplements; or be unsafe, so it is important for clinicians to discuss dietary supplement use with patients. This article provides an overview of dietary supplement requirements related to safety, manufacturing, labeling, advertising, and adverse event reporting; discusses tainted supplements and the FDA's and Federal Trade Commission's enforcement actions against dietary supplements; and offers recommendations to clinicians on matters of key clinical and ethical importance during clinical encounters.

摘要

膳食补充剂不需要美国食品和药物管理局(FDA)的上市前批准,但它们可能会有副作用;与药物、食物或其他补充剂相互作用;或者不安全,因此临床医生与患者讨论膳食补充剂的使用非常重要。本文概述了与安全性、制造、标签、广告和不良事件报告相关的膳食补充剂要求;讨论了受污染的补充剂以及 FDA 和联邦贸易委员会对膳食补充剂的执法行动;并就临床医生在临床接触期间的关键临床和伦理问题提供了建议。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验